ARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACCARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACCARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACC

ARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACC

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪8.16 M‬USD
Fund flows (1Y)
‪5.95 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
−2.7%
Shares outstanding
‪1.53 M‬
Expense ratio
0.79%

About ARK INVEST UCITS ICAV GENOMIC REVOLUTION UCITS ETF USD ACC


Issuer
ARK Investment Management LP
Brand
ARK
Inception date
Apr 12, 2024
Index tracked
No Underlying Index
Replication method
Synthetic
Management style
Active
Primary advisor
ARK Investment Management LLC
ISIN
IE000O5M6XO1
The investment objective of the Fund is to generate long term capital growth (5 years or more)

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Active
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of February 20, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Technology Services
Stocks99.61%
Health Technology76.28%
Technology Services15.73%
Health Services7.60%
Bonds, Cash & Other0.39%
Cash0.39%
Stock breakdown by region
91%8%
North America91.69%
Europe8.31%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows